Selpercatinib is the first drug from Loxo’s pipeline that Lilly has brought to market. Prior to the acquisition, Loxo won approval of Vitrakvi, which targets a different genetic mutation and is sold by Bayer AG. SAN JUAN, Puerto Rico (AP) – U.S. Education Secretary Miguel Cardona said Monday that Puerto Rico will receive nearly $4 …